aap Implantate completed the sale of its aapBiomaterials subsidiary. The buyer is Keensight Capital, and aap received proceeds of ~€36.6MM (~€35MM/~US $40MM after transaction costs).
aap is now a pure player in trauma with three platform technologies: LOQTEQ®, silver coating and magnesium.
Year to date, the orthopaedic industry has observed 18 M&A transactions—11 in 1Q16 alone, up one from 10 in 1Q15. Keep track of who/what/where with the M&A spreadsheet. It’s a Membership benefit.
aap Implantate completed the sale of its aapBiomaterials subsidiary. The buyer is Keensight Capital, and aap received proceeds of ~€36.6MM (~€35MM/~US $40MM after transaction costs).
aap is now a pure player in trauma with three platform technologies: LOQTEQ®, silver coating and magnesium.
aap Implantate completed the sale of its aapBiomaterials subsidiary. The buyer is Keensight Capital, and aap received proceeds of ~€36.6MM (~€35MM/~US $40MM after transaction costs).
aap is now a pure player in trauma with three platform technologies: LOQTEQ®, silver coating and magnesium.
Year to date, the orthopaedic industry has observed 18 M&A transactions—11 in 1Q16 alone, up one from 10 in 1Q15. Keep track of who/what/where with the M&A spreadsheet. It’s a Membership benefit.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
